Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Bulletin from the Extraordinary Shareholders’ Meeting in Incoax Networks AB on August 13, 2020

Today, on August 13, 2020, an extraordinary shareholders’ meeting was held in InCoax Networks AB. A summary of the resolutions adopted follows below. All resolutions were adopted with the required majority of votes.Resolution on rights issue of sharesThe extraordinary shareholders’ meeting resolved on a rights issue of a maximum of 9,147,465 shares. Those who are registered as shareholders in the company on the record date August 20, 2020 will receive one (1) subscription right per existing share. Two (2) subscription rights entitle to subscription of one (1) new share at a subscription

Interim report, 1 January–30 June 2020

Extremely volatile quarter· Total incomeQ2: SEK 300.7 (252.7) millionHY1: SEK 649.4 (563.4) million  · EBITDAQ2: SEK 114.1 (53.3) millionHY1: SEK 237.3 (134.9) million  · Result before taxQ2: SEK 28.3 (–39.2) millionHY1: SEK 57.3 (–37.4) million  · Result per share after taxQ2: SEK 0.59 (–0.82)HY1: SEK 1.20 (–0.78) Events after the end of the quarter · Stena Performance CVC contract extended to May 2021 · Operational challenges of crew changes and Covid-19 Key figures · Total income, SEK million 649.4 (563.4) · EBITDA, SEK million 237.3 (

Musti Group Plc: Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act

Stock Exchange Release 13 August 2020, at 1:50 p.m.Musti Group Plc (the “Company”) has today received a notification in accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act from Investment AB Öresund (publ) (”Investment AB Öresund”), according to which Investment AB Öresund’s holding of the shares and votes of the Company increased above the threshold of 5 percent on 13 August 2020. Investment AB Öresund holds a total of 1,710,309 shares corresponding to an ownership of 5.10 percent in the Company’s shares and votes. Total positions of Investment AB Öresund

Invitation to the presentation of the Q2 2020 results on Tuesday 18 August 2020 at 10:00 (CET)

Nordic Mining hereby invites you to the presentation of the results for the second quarter of 2020 and company update on Tuesday 18 August 2020 at 10:00 (CET). The presentation will be held digitally due to the Coronavirus restrictions. The interim report and the presentation will be published at the Oslo Stock Exchange and on Nordic Mining's webpage (www.nordicmining.com) in advance of the presentation. The presentation and Q&A session will be held in English and transferred via webcast. You will have the opportunity to post questions online throughout the webcast session. The

Troax Group: Interim Report January- June 2020

Hillerstorp 13 August 2020, 12:30 CETAPRIL - JUNE · Order intake decreased by 19 percent to 37,7 (46,6) MEUR. Adjusted for currency the decrease was 19 percent. · Sales decreased organically by 15 percent to 35,9 (42,3) MEUR. Adjusted for currency the decrease was 15 percent. · Operating profit decreased to 6,4 (8,5) MEUR. · Operating margin decreased to 17,8 (20,1) percent. · Financial net was -0,2 (-0,2) MEUR. · Profit after tax decreased to 4,7 (6,3) MEUR. · Earnings per share after dilution amounted to 0,08 (0,11) EUR. · Due to Corona, the Group received

WEKO to offer a new way of applying Polygiene; spraying means saving

WEKO is a leading German supplier of industrial application systems for surface finishing. Together with Polygiene it will now offer solutions for applying Polygiene ViralOff as a spray of microdroplets. This saves up to 80% of water, 80% of chemistry and 90% of drying energy.   The machines and application solutions will be sold to existing and new customers which include numerous leading textile treatment and manufacturing mills. This means Polygiene will further reinforce their presence in the whole value chain, from branded consumer and professional products brand labels to

Qt GROUP OYJ - Managers' Transactions

Stock Exchange Release August 13, 2020 1:00 pm ____________________________________________ Person subject to the notification requirementName: Ingman, RobertPosition: Member of the boardIssuer: Qt Group PlcLEI: 743700GO2XU2ZYYDKW67 Notification type: INITIAL NOTIFICATIONReference number: 743700GO2XU2ZYYDKW67_20200813093224_2____________________________________________ Transaction date: 2020-08-12Venue: FNFIInstrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENTISIN: FI4000414420Nature of the transaction: ACQUISITION  Transaction

Qt GROUP OYJ - Managers' Transactions

Stock Exchange Release August 13, 2020 1:00 pm ____________________________________________ Person subject to the notification requirementName: Holländer, Petteri Position: Other senior managerIssuer: QT Group OyjLEI: 743700GO2XU2ZYYDKW67 Notification type: INITIAL NOTIFICATIONReference number: 743700GO2XU2ZYYDKW67_20200813111640_5____________________________________________ Transaction date: 2020-08-12Venue: FIRST NORTH FINLAND (FNFI)Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENTISIN: FI4000414420Nature of the transaction:

Qt GROUP OYJ - Managers' Transactions

Stock Exchange Release August 13, 2020 1:00 pm ____________________________________________ Person subject to the notification requirementName: Pälsi, Mika Position: Other senior managerIssuer: QT Group OyjLEI: 743700GO2XU2ZYYDKW67 Notification type: INITIAL NOTIFICATIONReference number: 743700GO2XU2ZYYDKW67_20200813111414_3____________________________________________ Transaction date: 2020-08-12 Venue: FIRST NORTH FINLAND (FNFI)Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENTISIN: FI4000414420Nature of the transaction: DISPOSAL(

Qt GROUP OYJ - Managers' Transactions

Stock Exchange Release August 13, 2020 1:00 pm ____________________________________________ Person subject to the notification requirementName: Turunen, Tuukka Position: Other senior managerIssuer: QT Group OyjLEI: 743700GO2XU2ZYYDKW67 Notification type: INITIAL NOTIFICATIONReference number: 743700GO2XU2ZYYDKW67_20200813111537_4____________________________________________ Transaction date: 2020-08-12Venue: FIRST NORTH FINLAND (FNFI)Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENTISIN: FI4000414420Nature of the transaction: DISPOSAL

Qt GROUP OYJ - Managers' Transactions

Stock Exchange Release August 13, 2020 1:00 pm ____________________________________________ Person subject to the notification requirementName: Varelius, JuhaPosition: Chief Executive OfficerIssuer: QT Group OyjLEI: 743700GO2XU2ZYYDKW67 Notification type: INITIAL NOTIFICATIONReference number: 743700GO2XU2ZYYDKW67_20200813111744_6____________________________________________ Transaction date: 2020-08-12 Venue: FIRST NORTH FINLAND (FNFI)Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENTISIN: FI4000414420Nature of the transaction:

Photocure ASA: Invitation to presentation of second quarter and first half year 2020 financial results

Oslo, Norway, 13 August 2020: Photocure ASA (Photocure, PHO: OSE) will announce the second quarter and first half year 2020 financial results on Tuesday 18 August 2020 at 07:00 CET and invites investors, analysts and the media to a presentation at 14:00 CET the same day.The investor presentation will be streamed live and be hosted by Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and questions can be submitted throughout the event.The quarterly report and presentation will be published at 07:00 CET and will be publicly available at www.photocure.com.

Photocure appoints Genotests as exclusive partner for Hexvix[ ]in Chile

Oslo, Norway, 13 August 2020: Photocure ASA (OSE: PHO), today announced the appointment of Genotests SpA as the exclusive distributor for the commercialization of Hexvix[®] in Chile.“We are proud to take our first step into the South American continent and make Hexvix accessible to Chilean bladder cancer patients. Chile is a stable, well regulated market with a strong economy, and Genotests is well positioned to leverage their network of urologists and uro-oncologists both in the private and public hospitals”, says Dan Schneider, President and CEO of Photocure. Photocure has appointed

New Clas Ohlson store opened in Trondheim, Norway

Today at 9 am Clas Ohlson opened a new store in Sirkus Shopping, Trondheim, Norway. The area Trondheim east is growing and developing rapidly with new housing, schools and offices. Our new store in Sirkus will strengthen our presence and customer offer in this city.“Our new Sirkus store will strengthen our position in the area and give our customers increased availability to our products and services,” Rune Johansen, Operations manager Norway, explains.  Our customer offering at Sirkus shopping also includes Click & Collect for a fast and simple customer experience. The online order is

KEBNI STRENGTHENING LEADERSHIP FOR LAND MOBILE

KebNi is hiring Erik Wiberg as Managing Director for its Land Mobile business. Erik Wiberg has extensive sales and operational experience from the satellite communication industry.KebNi is strengthening its leadership by the recruitment of Erik Wiberg in a new position as Managing Director for its Land Mobile business. Land Mobile covers both "Comms on the Move" acquired earlier in the year from ReQuTech and Satmission solutions. Erik Wiberg has a diverse and global background within the telcom and satcom industries. He has 18 years of experience in the satcom industry with positions

Vicore Pharma publishes a prospectus for admission to trading of shares on Nasdaq Stockholm in connection with a directed share issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA,  CANADA, HONG KONG, JAPAN, NEW ZEELAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND,  THE UNITED KINGDOM , THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION MEASURES OR ANY OTHER MEASURE UNDER APPLICABLE LAW. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO, OR INVITATION TO, ACQUIRE OR SUBSCRIBE FOR ANY FINANCIAL INSTRUMENTS IN VICORE PHARMA IN ANY JURISDICTION.Gothenburg, August 13, 2020 – The board of

Södra strengthens its work within public affairs

Marcus Svensson has been appointed Head of Public Affairs at Södra. He will organise, coordinate and manage Södra’s work within public affairs going forward.“Our industrial operations and terms for forest ownership are largely dependent on external decisions taken by the authorities and politicians. During the last few years, we have seen issues concerning sustainability, fossil-fuel independence and a circular economy as well as ownership, use and forest products rise in importance on the agenda at national as well as EU level. This is a development we are now addressing by strengthening

Lipum prepares for LSX Nordic Virtual event

News: Umeå, 13 August 2020. Lipum participate in LSX Nordic Viritual event 1-4 September.LSX is a community of senior life science decision makers where they connect senior life science executives with the capital, intelligence, innovation, and partners the companies need to grow their businesses. “Through these conferences and networking events we have the possibility to share our progress and hopefully reach out to investors and industry stakeholders. It´s a perfect arena for Lipum”, says Einar Pontén, CEO.

CELLINK announces strategic partnership with Carcinotech to advance 3D-bioprinting technology for cancer research

CELLINK, a leading provider of innovative biomaterials and technologies for 3D bioprinting applications in the life sciences, announced a collaboration with Carcinotech, which focuses on the production of cancer research models for drug testing, cancer drug discovery and the study of cancer biology. This collaboration seeks to use CELLINK’s patent-pending bioinks to help Carcinotech develop its proprietary 3D-bioprinted cancer research model that will mimic cancer systems found in the human body on a micro-size chip. One of the biggest challenges in cancer drug testing and treatments

Gapwaves receives antenna prototype order from global tech giant

Gapwaves, a Sweden-based company with patented technology for millimeter wave waveguide antennas, today announced an order for 77 GHz antenna prototypes from a global tech giant. The order is for test and evaluation purposes with expected delivery during Q3 2020 and a value of ca 1.5 MSEK.Gapwaves CEO Lars-Inge Sjöqvist comments: ”We are very excited about this order and the opportunity to present Gapwaves waveguide technology. Our customer is a true leader in technology innovation and we are very enthustiastic to provide a waveguide antenna representing high performance and compact form

FluoGuide A/S and LI-COR Biosciences sign agreement to develop uPAR targeted products to guide oncology surgery using LI-COR’s proprietary next-generation fluorophore IRDye 800CW

Copenhagen, Denmark, 13 August 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) has signed a non-exclusive supply and licensing agreement with the US company LI-COR Biosciences. The agreement will help FluoGuide broaden its portfolio of uPAR-targeted products with features unique to IRDye 800CW, such as deep tissue targeting. With this latest agreement, FluoGuide is well-positioned to maximize the clinical and commercial potential of uPAR-targeted products in fluorescent-guided surgery for cancer.FluoGuide’s strategic development plan centers on advancing its lead product, FG001, for

There are no items matching the current filter
There are no more items matching the current filter
Back to top